alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 4.1


 


THE BANK OF NEW YORK MELLON


NEW YORK’S FIRST BANK-FOUNDED 1784 BY ALEXANDER HAMILTON


 


 


2 HANSON PLACE, 12TH FLOOR, BROOKLYN,
N.Y. 11217


 


 


 


December 22, 2015


 


Hennion & Walsh, Inc.


2001 Route 46, Waterview Plaza


Parsippany, New Jersey 07054


 


Smart Trust, Strategic Growth & Income
Trust, Series 8


 


Dear Sirs:


The Bank of New York
Mellon is acting as trustee for Smart Trust, Strategic Growth & Income Trust, Series 8 set forth above (the “Trust”).
We enclosed a list of the Securities to be deposited in the Trust on the date hereof. The prices indicated therein reflect our
evaluation of such Securities as of close of business on December 21, 2015, in accordance with the valuation method set forth in
the Standard Terms and Conditions of Trust and Trust Agreement. We consent to the reference to The Bank of New York Mellon as the
party performing the evaluations of the Trust Securities in the Registration Statement (No. 333-207607) filed with the Securities
and Exchange Commission with respect to the registration of the sale of the Trust Units and to the filing of this consent as an
exhibit thereto.


 


 


Very truly yours,


 


/s/ GERARDO CIPRIANO________________


Gerardo Cipriano


Vice President
QuickLinks
 -- Click here to rapidly navigate through this document









































 
 

  Exhibit 4.7    
    




 

 






			
	



 	 	



 



 

 December 23,
2015 


VIA SEDAR — PROJECT #02429894  


Alberta Securities Commission  


Dear Sirs: 

 






			
	Re:	 	TransCanada PipeLines Limited

Final Short Form Base Shelf Prospectus



 

 We
refer to the final short form base shelf prospectus dated December 23, 2015 (the "Prospectus") of TransCanada PipeLines Limited
(the "Corporation") relating to the offering by the Corporation of up to US$4,000,000,000 aggregate principal amount of unsecured debt
securities. 


We
hereby consent to the references to our firm name under the headings "Enforceability of Civil Liabilities", "Legal Matters", "Interest of Experts" and "Documents Filed as Part of the Registration
Statement" in the Prospectus and to the use of our opinion under the heading "Enforceability of Civil Liabilities" in the Prospectus. 


We
confirm that we have read the Prospectus and have no reason to believe that there are any misrepresentations in the information contained in the Prospectus that are derived from our opinion
referred to therein or that are within our knowledge as a result of the services we performed in connection with such opinion. 

 






			
	 	 	Yours truly,
	

 	
 	
 
	 	 	(signed) "Blake, Cassels & Graydon LLP"



 

  









  


 












QuickLinks



Exhibit 4.7
<PAGE>

                               Bank One, Michigan
                               3245 Elizabeth Lake Road      Phone: 248-738-6125
                               Waterford, Michigan 48328     Fax: 248-738-6117

                               SHARON FAUGHT
                               VICE PRESIDENT


[BANK ONE LOGO]

                                        734-975-9115

May 31, 2002

Art Smith
Power Efficiency Corporation
4220 Varsity Dr.
Suite E
Ann Arbor, Mi. 48108

Re: 7153428944-Expired Credit Facility

Dear Mr. Smith;

Pursuant to your request, please be advised that Bank One will forbear from
taking any collection activity concerning the above referenced expired loan
until June 17, 2002.

By this letter, the Bank is not waiving any of the existing defaults. Upon the
occurrence of a further default, or an action that threatens the Bank's
collateral, the Bank reserves the right, in its sole discretion to immediately
demand payment of all amounts owed and take those actions it deems appropriate
to protect its interests. Nothing in our discussions or anything contained in
this letter shall be deemed to constitute a waiver of or shall waive, any of the
defaults existing as of the dates hereof, or any of the Bank's remedies provided
in its agreements with the Borrower.




Sincerely,

/s/ Sharon A. Faught
--------------------
Sharon A. Faught
Vice President

SAF
In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS

(Filed: September 23, 2014)

 

* * * * * * * * * * * * * * * UNPUBLISHED

CAROLINE COURBOIS, *

* No. 13-939V

Petitioner, *

*

v. * Special Master Hamilton-Fieldman

* 

SECRETARY OF HEALTH * 

AND HUMAN SERVICES, * Ruling on Entitlement; Conceded;

* Influenza (Flu) Vaccine; Shoulder Injury

Respondent. * Related to Vaccine Administration

* (SIRVA).

* * * * * * * * * * * * * * *

Peter Meyers, National Law Center, Washington, D.C., for Petitioner.

Michael Milmoe, United States Department of Justice, Washington, D.C., for Respondent.

RULING ON ENTITLEMENT1

On November 27, 2013, Caroline Courbois (“Petitioner”) filed a petition for 

compensation under the National Vaccine Injury Compensation Program (“the Program”).

2

Petitioner alleged that an influenza (“flu”) vaccination she received on January 10, 2013 caused 

her to suffer from a shoulder injury related to vaccine administration (“SIRVA”). 

On September 22, 2014, Respondent filed a report pursuant to Vaccine Rule 4(c) in 

which she concedes that Petitioner is entitled to compensation in this case. Specifically, 

Respondent agrees that Petitioner’s alleged injury is consistent with SIRVA. Based on a review 

1 Because this unpublished ruling contains a reasoned explanation for the action in this case, the 

undersigned intends to post this decision on the website of the United States Court of Federal 

Claims, in accordance with the E-Government Act of 2002 § 205, 44 U.S.C. § 3501 (2006). In 

accordance with the Vaccine Rules, each party has 14 days within which to request redaction “of 

any information furnished by that party: (1) that is a trade secret or commercial or financial in 

substance and is privileged or confidential; or (2) that includes medical files or similar files, the 

disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 

18(b). Further, consistent with the rule requirement, a motion for redaction must include a 

proposed redacted decision. If, upon review, the undersigned agrees that the identified material 

fits within the requirements of that provision, such material will be deleted from public access.

2 The Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, 42 

U.S.C. §§ 300aa-10 et seq. (hereinafter “Vaccine Act” or “the Act”). Hereafter, individual 

section references will be to 42 U.S.C. § 300aa of the Act.

 
of the medical records, Respondent concludes that Petitioner has satisfied all legal prerequisites 

for compensation under the Act. 

A special master may determine whether a petitioner is entitled to compensation based 

upon the record. A hearing is not required. §300aa-13; Vaccine Rule 8(d). In light of 

Respondent’s concession and a review of the record, the undersigned finds that Petitioner is 

entitled to compensation. This matter shall now proceed to the damages phase.

IT IS SO ORDERED.

s/ Lisa Hamilton-Fieldman

 Lisa Hamilton-Fieldman

Special Master

2
EXHIBIT
32.2
 
 STATEMENT
REQUIRED BY 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT
 TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
 In
connection with the Quarterly Report on Form 10-Q of Décor Products
International, Inc., (the "Company") for the three and nine months ended
September 30, 2009, as filed with the Securities and Exchange Commission on the
date hereof (the "Report"), I, Wai Fai Law, Chief Financial Officer, of the
Company, certify that:
  
 *   the
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
 
 *   information
contained in the Report fairly presents, in all material respects, our
consolidated financial condition and results of operations.
 
 
 /s/ Wai Fai
Law
 Wai Fai
Law
 Chief
Financial Officer
 
 
 Date:
November 19, 2009
 
 
 This
certification accompanies this Report pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the
Sarbanes-Oxley Act of 2002, be deemed filed by us for purposes of Section 18 of
the Securities Exchange Act of 1934, as
amended.
THE SECRETARY OF HEALTH AND HUMAN SERVICES 

WASHINGTON. D.C. 20201 

F'EB - 1 2807 

The Honorable Richard Cheney 

President of the United States Senate 

Washington, D.C. 205 10 

Dear Mr. President: 

Pursuant to the Energy Employees Occupational Illness Compensation Program Act of 

2000 and 42 C.F.R. Part 83, a petition was filed on behalf of workers from the Allied Chemical 

Corporation Plant in Metropolis, Illinois, to be added to the Special Exposure Cohort (SEC). 

On December 12, 2006, the Centers for Disease Control and Prevention's (CDC) 

National Institute for Occupational Safety and Health (NIOSH) presented its findings on the 

petition evaluation to the Advisory Board on Radiation and Worker Health ("the Board") at 

the Board meeting in Naperville, Illinois. On January 3, 2007, I received the Board's 

recommendation concerning this petition. 

Based upon consideration of the deliberations, findings, and recommendations of the 

Board and concurrence by the Director, NIOSH, and also by the Director, CDC, I have 

designated the following class for addition to the SEC: 

Atomic Weapons employees who were monitored or should have been monitored for 

exposure to ionizing radiation while working at Allied Chemical Corporation Plant in 

Metropolis, Illinois, from January 1, 1959, through December 3 1, 1976, and who were 

employed for a number of work days aggregating at least 250 work days or in 

combination with work days within the parameters established for one or more other 

classes of employees in the SEC. 

The criteria and findings upon which this designation is based are provided in the 

enclosed report. 

Please call me if you have any further questions regarding this matter. 

Sincerely, 

~khael 0. Leavitt 

Enclosure
<TABLE> <S> <C>

<ARTICLE> 5
<CURRENCY> U.S. DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          SEP-30-1998
<PERIOD-START>                             OCT-01-1997
<PERIOD-END>                               SEP-30-1998
<EXCHANGE-RATE>                                      1
<CASH>                                         470,742
<SECURITIES>                                 7,944,249
<RECEIVABLES>                                1,150,758
<ALLOWANCES>                                 (107,463)
<INVENTORY>                                          0
<CURRENT-ASSETS>                             9,770,865
<PP&E>                                       1,820,051
<DEPRECIATION>                                 599,452
<TOTAL-ASSETS>                              11,334,212
<CURRENT-LIABILITIES>                        1,044,644
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                    14,928,832
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                10,289,568
<SALES>                                      4,830,882
<TOTAL-REVENUES>                             4,830,882
<CGS>                                        1,803,895
<TOTAL-COSTS>                                5,906,517
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (2,371,125)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (2,371,125)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (2,371,125)
<EPS-PRIMARY>                                    (.41)
<EPS-DILUTED>                                    (.41)
        

</TABLE>
Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of First Savings Financial Group, Inc. and Subsidiaries (the
Company) on Form 10-Q for the period ended December 31, 2008, as filed with the Securities and Exchange Commission (the Report), I, Anthony A. Schoen, Chief Financial Officer of the Company, certify, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies
with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the
Report fairly presents, in all material respects, the financial condition and result of operations of the Company as of and for the period covered by the Report.



|                        |  |  |  |     |  |                        
|----------------------- |  |  |  | --- |  | -----------------------
|DATE: February 17, 2009 |  |  |  | BY: |  | /s/ Anthony A. Schoen  
|                        |  |  |  |     |  | Anthony A. Schoen      
|                        |  |  |  |     |  | Chief Financial Officer
HPC Acquisitions, Inc.


File No. 0-53248


Form 10-Q


Quarter ended March 31, 2010





Certification Pursuant to 18 U.S.C. Section 1350, as Adopted


Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002





In connection with the Quarterly Report of HPC Acquisitions, Inc. (the “Company”) on Form 10-Q for the period ending March 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Craig S. Laughlin, Chief Executive and Chief Financial Officer of the Company, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:




(1)
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.






Date: May 13, 2010
By:
/s/ Craig S. LaughlinCraig S. LaughlinChief Executive Officerand Chief Financial Officer




A signed original of this written statement required by Section 906 has been provided to HPC Acquisitions, Inc. and will be retained by HPC Acquisitions, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
Presidential Documents

22203 

Federal Register 

Vol. 75, No. 81 

Wednesday, April 28, 2010 

Title 3— 

The President 

Memorandum of April 20, 2010 

Delegation of Certain Functions Under Section 1265 of the 

National Defense Authorization Act for Fiscal Year 2010 

Memorandum for the Secretary of State 

By the authority vested in me as President by the Constitution and the 

laws of the United States, including section 301 of title 3, United States 

Code, I hereby delegate to you the functions and authority conferred upon 

the President by section 1265 of the National Defense Authorization Act 

for Fiscal Year 2010, Public Law 111–84, to make the specified report 

to the Congress. 

You are authorized and directed to notify the appropriate congressional 

committees and publish this memorandum in the Federal Register. 

THE WHITE HOUSE, 

Washington, April 20, 2010 

[FR Doc. 2010–10037 

Filed 4–27–10; 8:45 am] 

Billing code 4710–10–P 


srobinson on DSKHWCL6B1PROD with MISCELLANEOUSOB#1.EPS</GPH>
**Exhibit 32.2**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350,**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

I, Judy A. Schmeling, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that, to myknowledge: 

(1) the Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2010 of HSN, Inc. (the“Report”) which this statement accompanies fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and 

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operationsof HSN, Inc. 

Dated: May 5, 2010
[Federal Register Volume 73, Number 31 (Thursday, February 14, 2008)]
[Notices]
[Page 8708]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 08-680]


-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

U.S. Customs and Border Protection


Accreditation and Approval of SGS North America, Inc., as a 
Commercial Gauger and Laboratory

AGENCY: U.S. Customs and Border Protection, Department of Homeland 
Security.

ACTION: Notice of accreditation and approval of SGS North America, 
Inc., as a commercial gauger and laboratory.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that, pursuant to 19 CFR 151.12 and 19 
CFR 151.13, SGS North America, Inc., 16642A Jacintoport Blvd., Houston, 
TX 77015, has been approved to gauge and accredited to test petroleum 
and petroleum products, organic chemicals and vegetable oils for 
customs purposes, in accordance with the provisions of 19 CFR 151.12 
and 19 CFR 151.13. Anyone wishing to employ this entity to conduct 
laboratory analyses and gauger services should request and receive 
written assurances from the entity that it is accredited or approved by 
the U.S. Customs and Border Protection to conduct the specific test or 
gauger service requested. Alternately, inquires regarding the specific 
test or gauger service this entity is accredited or approved to perform 
may be directed to the U.S. Customs and Border Protection by calling 
(202) 344-1060. The inquiry may also be sent to <a href="/cdn-cgi/l/email-protection#f7949587d99b96959f86b7939f84d9909881"><span class="__cf_email__" data-cfemail="bfdcddcf91d3deddd7ceffdbd7cc91d8d0c9">[email protected]</span></a>. 
Please reference the website listed below for a complete listing of CBP 
approved gaugers and accredited laboratories. http://cbp.gov/xp/cgov/import/operations_support/labs_scientific_svcs/commercial_gaugers/.

DATES: The accreditation and approval of SGS North America, Inc., as 
commercial gauger and laboratory became effective on May 17, 2007. The 
next triennial inspection date will be scheduled for May 2010.

FOR FURTHER INFORMATION CONTACT: Commercial Gauger Laboratory Program 
Manager, Laboratories and Scientific Services, U.S. Customs and Border 
Protection, 1300 Pennsylvania Avenue, NW., Suite 1500N, Washington, DC 
20229, 202-344-1060.

    Dated: January 31, 2008.
Ira S. Reese,
Executive Director, Laboratories and Scientific Services.
[FR Doc. 08-680 Filed 2-13-08; 8:45 am]
BILLING CODE 9111-14-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
EXHIBIT 32.1





CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the quarterly report of Cemtrex, Inc. (the “Company”) on Form 10-Q for the six month period ended March 31, 2011, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Arun Govil, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:





(1)
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.





/s/ Arun GovilArun GovilChief Executive Officer

and Principal Executive Officer

May 16, 2011


A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
EXHIBIT 31.2

Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002



I, Matt Colbert, certify that:



1.

I have reviewed this annual report on Form 10-KSB of Lifestream Technologies, Inc.;



2.

Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;



3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;



4.

The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:



a)

Designed such disclosure controls and procedures, or caused such disclosure controls to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;



b)

Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and



c)

Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and



5.  The registrants other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of registrants board of directors (or persons performing the equivalent functions):



a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and



b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.



Date:  October 12, 2005



|/s/ MATTCOLBERT                               
|----------------------------------------------
|Matt Colbert                                  
|Interim Chief Accounting and Financial Officer